Lv55
1010 积分 2023-08-04 加入
740 A randomised controlled trial of fesoterodine in subjects with overactive bladder and suboptimal response to tolterodine extended release: Results from the AFTER study
6天前
已完结
A new once-daily formulation of tolterodine provides superior efficacy and is well tolerated in women with overactive bladder
8天前
已完结
Health-related quality of life of patients with overactive bladder receiving immediate-release tolterodine
8天前
已完结
Prospective, Randomized, Multicenter Trial of Peroneal Electrical Transcutaneous Neuromodulation vs Solifenacin in Treatment-naïve Patients With Overactive Bladder
8天前
已关闭
Prediction Trough Concentrations of Valproic Acid Among Chinese Adult Patients with Epilepsy Using Machine Learning Techniques
9天前
已完结
1089 Quality of life analyses from NEPTUNE, a phase 3 trial of combination therapy with tamsulosin OCAS™ and solifenacin in men with lower urinary tract symptoms
10天前
已完结
What is the best first choice oral drug therapy for OAB?
16天前
已完结
Comparisons of approaches to pelvic floor muscle training for urinary incontinence in women
17天前
已完结
Real-World Adherence to and Persistence with Vibegron in Patients with Overactive Bladder: A Retrospective Claims Analysis
18天前
已完结
Longitudinal Fluctuations in Treatment Response After OnabotulinumToxinA and Sacral Neuromodulation for Refractory Urgency Incontinence
20天前
已完结
皖公网安备34019202002308
